作者
A.M. Api,D. Belsito,D. Botelho,M. Bruze,G.A. Burton,M.A. Cancellieri,H. Chon,M.L. Dagli,W. Dekant,C. Deodhar,A.D. Fryer,L. Jones,K. Joshi,M. Kumar,A. Lapczynski,M. Lavelle,I. Lee,D.C. Liebler,H. Moustakas,J. Muldoon,T.M. Penning,G. Ritacco,J. Romine,N. Sadekar,T.W. Schultz,D. Selechnik,F. Siddiqi,I.G. Sipes,G. Sullivan,Y. Thakkar,Y. Tokura
摘要
• Hexyl salicylate; a safety assessment based on RIFM's criteria. • A safety assessment based on 7 human health endpoints plus environmental. • All endpoints were cleared using target data, read-across, and/or TTC.